As of November 2026, CNC's current EPS stands at $2.96, according to the latest financial reports. Centene's EPS for 2025 amounted to -$13.53, marking a drop from $6.33 in 2024. CNC reported an EPS of -$0.14 for the quarterly report ending on Sep 30, 2026.
For 2025, Centene's EPS was -$13.53, a drop of 313.7% from $6.33 in 2024. The quarterly per-share earnings for the period ending Sep 30, 2026, was -$0.14, indicating a 99% increase from the same quarter last year. CNC's 12-month EPS stands at $2.96 as of September 2026. Centene's annual EPS in 2024 stood at $6.33, a 27.4% increase year-over-year.
Centene has registered an increase in EPS of 99% during the last 12 months (YoY, quarterly).
| Stock name | Price to Earnings | EPS grwoth 1Y | EPS grwoth 3Y | EPS grwoth 5Y |
|---|---|---|---|---|
| CI Cigna Group (The) | 13.01 | 82.3% | 1% | -0.7% |
| UNH Unitedhealth Group Inc | 23.08 | -15.1% | -14.8% | -3.9% |
| CNC Centene Corp | 23.74 | -313.7% | N/A | N/A |
| HUM Humana Inc | 42.5 | -1.4% | -23.7% | -17.3% |
| MOH Molina Healthcare Inc | N/A | -56.5% | -13.3% | -4.8% |
All data is based on quarterly TTM periods, unless otherwise specified.